Amanote Research
Register
Sign In
Oral Buflomedil in the Prevention of Cardiovascular Events in Patients With Peripheral Arterial Obstructive Disease: A Randomized, Placebo-Controlled, 4-Year Study
Circulation
- United States
doi 10.1161/circulationaha.107.706374
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cardiovascular Medicine
Physiology
Cardiology
Date
February 12, 2008
Authors
Unknown
Publisher
Ovid Technologies (Wolters Kluwer Health)
Related search
Indobufen in the Prevention of Thromboembolic Complications in Patients With Heart Disease. A Randomized, Placebo-Controlled, Double-Blind Study
Circulation
Cardiovascular Medicine
Physiology
Cardiology
A Double - Blind, Placebo - Controlled, Randomized Study Comparing Quetiapine With Placebo, Along With Oral Naltrexone, in the Treatment of Opioid Dependent Patients
Journal of Evolution of Medical and Dental Sciences
Association of Peripheral Arterial Disease With All-Cause Mortality, Cardiovascular Mortality and Cardiovascular Events
Angiology: Open Access
Predictive Value of Reactive Hyperemia for Cardiovascular Events in Patients With Peripheral Arterial Disease Undergoing Vascular Surgery
Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular Medicine
Cardiology
Antiplatelet Therapy in the Primary Prevention of Cardiovascular Disease in Patients With Chronic Obstructive Pulmonary Disease: A Randomised Controlled Proof-Of-Concept Trial
ERJ Open Research
Pulmonary
Respiratory Medicine
A Randomized, Double-Blind, Placebo-Controlled Study of Oral Antioxidant Supplement Therapy in Patients With Dry Eye Syndrome
Clinical Ophthalmology
Ophthalmology
Indacaterol Improves Lung Hyperinflation and Physical Activity in Patients With Moderate Chronic Obstructive Pulmonary Disease - A Randomized, Multicenter, Double-Blind, Placebo-Controlled Study
BMC Pulmonary Medicine
Pulmonary
Respiratory Medicine
Mitochondrial DNA Copy Number Is Associated With All‐cause Mortality and Cardiovascular Events in Patients With Peripheral Arterial Disease
Journal of Internal Medicine
Internal Medicine
Therapeutic Effect of Oral CF101 in Patients With Rheumatoid Arthritis: A Randomized, Double-Blind, Placebo-Controlled Phase II Study
Immunome Research
